NSCLC,” said David Hung, M.D., Founder, President and Chief Executive Officer of Nuvation Bio. “We believe one of the greatest threats to ROS1-positive lung cancer patients is disease progression, especially in the first-line setting. In pivotal...
These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly human-relevant territory. “AVA gives scientists unprecedented experimental capacity with the biological depth of...
infection during and after treatment with HADLIMA, including the possible development of tuberculosis (TB) in patients who tested negative for latent TB infection prior to initiating therapy. Lymphoma and other malignancies, some fatal, have been...
gonorrhoeae, Listeria monocytogenes, among others) Doxycycline may also be used as adjunctive therapy for acute intestinal amebiasis and for the treatment of trachoma, although complete eradication may not always be achieved. About Avenacy: Avenacy...
from treatment with ustekinumab products may be susceptible to these types of infections. Consider appropriate diagnostic testing (e.g., tissue culture, stool culture, as dictated by clinical circumstances). Pre-Treatment Evaluation of Tuberculosis...
in situ editing of the skin microbiome, and successfully expanding its Series B funding round to $35 million. This latest non-dilutive financial support strengthens Eligo's capacity to rapidly advance its clinical pipeline. Scaling up and advancing...
XPRIZE: XPRIZE is the recognized global leader in designing and executing large-scale competitions to solve humanity's greatest challenges. For over 30 years, our unique model has democratized crowd-sourced innovation and scientifically scalable...
productive FDA interactions and positive topline results from the Phase 1b trial, we have designed our RENEW trial to test the promise of our dual mechanism approach to targeting alveolar epithelial cell survival and the inhibition of profibrotic...
significant 20% increase in whole blood NAD+ levels three hours after infusion, as measured by NAD+ dried blood spot tests (MedRxiv). Study results demonstrated that NAD+ IV had a longer infusion time and was associated with a high prevalence of...
institute dedicated to combining advanced computational modeling using A.I. with translational research and clinical testing to accelerate the development of the next wave of precision medicines for inflammatory and autoimmune diseases, NImmune...
indicating a potential targeted effect beyond that expected by the magnitude of weight reduction. Findings from this latest post-hoc analysis, which included data from over 200 participants analyzed using AMRA® Researcher, indicate that decreases...
of prefilled syringes, autoinjectors, vials and pen-cartridge combinations, and incorporate extensive ISO-standard product testing capabilities and premium top-load cartoning technology. The campus also comprises capabilities for low- to...
a paradigm shift in wearable cardiac defibrillation. It combines the principles of human-centered design with the latest advancements in machine learning. With features like water resistance that allows for continuous protection during showering,...
strategic partners, clinical investigators and key opinion leaders to connect with the team at AACR to discuss these latest findings, the company's ongoing clinical development plans, and potential strategic collaborations.
stabilize RNA and DNA, allowing enhanced point of care and ambient temperature transport for laboratory based molecular testing and characterization.
technology. Innorna’s achievements have earned recognition as one of MIT Technology Review’s Global Top 50 Smartest Companies and Fortune China’s Most Socially Influential Startups. Guided by INNOVATION, INTEGRITY, EFFICIENCY, and OPENNESS, Innorna...
as well as improve patient adherence and outcomes. “With the FDA’s recent commitment to phasing out traditional animal testing in favor of new approach methodologies, Creyon’s platform is uniquely positioned to lead this next chapter in drug...
patients, and the availability of PGDx elio plasma focus Dx, The first and only kitted, pan-solid tumor liquid biopsy test authorized by the U.S. Food and Drug Administration (FDA) to identify patients who may benefit from targeted treatments....
development during early-stage clinical studies by detecting protein expression on cell surfaces that other liquid biopsy tests cannot identify. The technology is transforming cancer research, drug development, patient selection, and therapy...
This suggests that Tregitope depletion is a fundamental feature of antibody evolution. The observation was confirmed by testing some of the 'natural' and 'modified' Tregitope sequences in vitro. "This mechanism is likely relevant to immunity from...